ARCHIVES

FDA Approves Votrient For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 39 | October 23, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Internal Debate Ends With Move of Biometry Branch, Including SEER, From DCCP To DRCCA

September 23, 1983

New Risk Stratification Method For Prostate Cancer Described

November 28, 2003

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985

Study Confirms Cancer Risk Increase Due To Combined HRT

January 31, 2003

In Brief: La Jolla Foundation Receives Donated Buildings; Sinks Named Medical Director, Middlesex Hospital

April 27, 1990

Funding Opportunities Listed.

January 7, 2005